The ADAS‐Cog revisited: Novel composite scales based on ADAS‐Cog to improve efficiency in MCI and early AD trials
Author:
Affiliation:
1. Janssen Pharmaceutical Companies of Johnson & JohnsonRaritanNJ
2. Janssen Pharmaceutical Companies of Johnson & JohnsonSpringhousePA
3. Janssen Pharmaceutical Companies of Johnson & JohnsonTitusvilleNJ
4. Global R&D PartnersSan DiegoCA
Funder
National Institutes of Health
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Dana Foundation
Publisher
Wiley
Subject
Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2012.05.2187
Reference36 articles.
1. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
2. Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
3. Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
4. A new rating scale for Alzheimer's disease
5. Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of hs-CRP concentration on brain structure alterations and cognitive trajectory in Alzheimer’s disease;Frontiers in Aging Neuroscience;2023-08-01
2. Landmark Model-based Individual Dynamic Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease using Cognitive Screening;Current Alzheimer Research;2023-04
3. Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings;Neurology Clinical Practice;2023-04
4. Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach;Alzheimer's Research & Therapy;2023-03-20
5. State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3